Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve Annual audited financial results of the Company for the year ended March 31, 2025 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2024-25 and fixation of record date for determining the eligibility of shareholders.